<DOC>
	<DOCNO>NCT02054052</DOCNO>
	<brief_summary>Malignant pleural pericardial effusion common lung cancer , intrapleural drug injection important treatment . Non- cytotoxic drug include sclerosing effect produce pleurodesis , easy cause severe chest pain despite influence follow chemotherapy . Tumor angiogenesis important produce MPE . Bevacizumab administrate locally treat optic nerve sickness successfully anti-VEGF mechanism . So hypothesize intrapleural bevacizumab also effective treat MPE .</brief_summary>
	<brief_title>Intrapleural Bevacizumab Injection Malignant Effusion Lung Cancer</brief_title>
	<detailed_description>Inclusion Criteria : 1 . Histological cytological diagnosis non-small cell lung cancer . 2 . Cytological diagnosis malignant pleural pericardial effusion ( MPE ) 3 . Symptomatic MPE evaluate researcher 4 . Unsuitable reject systemic therapy tumor 5 . Continuous TKI treatment TKI-resistance 6 . Estimated survival 3 month . 7.18 year old Exclusion Criteria : 1 . Current recent ( within 10 day prior treatment ) use full amount inhibition platelet function , anticoagulant thrombolytic therapy , allow prophylactic anticoagulant 2 . Be allergic bevacizumab 3 . Pregnant lactate woman 4 . Pleural pericardial infection</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Pleural Effusion</mesh_term>
	<mesh_term>Pleural Effusion , Malignant</mesh_term>
	<mesh_term>Pericardial Effusion</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<criteria>1 . Histological cytological diagnosis nonsmall cell lung cancer . 2 . Cytological diagnosis malignant pleural pericardial effusion ( MPE ) 3 . Symptomatic MPE evaluate researcher 4 . Unsuitable reject systemic therapy tumor 5 . Estimated survival 3 month . 6.18 year old 1 . Current recent ( within 10 day prior treatment ) use full amount inhibition platelet function , anticoagulant thrombolytic therapy , allow prophylactic anticoagulant 2 . Be allergic bevacizumab 3 . Pregnant lactate woman 4 . Pleural pericardial infection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>non-small cell lung cancer</keyword>
	<keyword>malignant pleural effusion</keyword>
	<keyword>bevacizumab</keyword>
	<keyword>intrapleural injection</keyword>
	<keyword>pericardial effusion</keyword>
</DOC>